“…It has been believed for years that the first action of this drug is to stimulate the cardio-inhibitor centre in the medulla oblongata. Various studies of different features of its action have demonstrated this, and it has been repeatedly shown that when the drug is injected subcutaneously the first result is beyond question a slowing of the pulse rate (Sturgis et al, 1919, McGuigan, 1921Harris, 1921 ;Platz, 1922). This result occurs even with doses of 2 mg. (Bain and Broadbent, 1949).…”